Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

US Patent 7166704 · Granted Jan 23, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MUC16 monoclonal antibody and uses thereof2023
Methods of increasing delivery of anti-cancer agents to targets2021
Method of targeting glycoproteins to treat cancer2018
Compositions and methods for detection and treatment of cancer2016
Compositions and methods for the treatment of cancer2016
Compositions and methods for preventing or treating cancer2014
Compositions and methods for preventing or treating cancer2012
Compositions and methods for enhancing immune responses mediated by antigen-pres2008
Compositions and methods for inhibiting pancreatic cancer metastasis2006
MUC17 encoding nucleic acid sequences, polypeptides, antibodies and methods of u2006
MUCIN 4 expression as a marker for pancreatic cancer2006
Compositions and methods for enhancing immune responses mediated by antigen-pres2004